Does discontinuing latuda (lurasidone) cause an elevated white blood cell count?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, Stopping Latuda Does Not Cause Elevated WBC

Discontinuing Latuda (lurasidone) does not cause an elevated white blood cell count. In fact, the concern with Latuda and other atypical antipsychotics is the opposite—they can cause decreased WBC (leukopenia, neutropenia), not elevated WBC 1.

Understanding the Hematologic Effects of Latuda

During Active Treatment

The FDA label for Latuda specifically warns about leukopenia, neutropenia, and agranulocytosis as potential adverse effects during treatment 1. The prescribing information recommends:

  • Performing complete blood counts (CBC) in patients with pre-existing low WBC or history of leukopenia/neutropenia
  • Considering discontinuation if a clinically significant decline in WBC occurs 1

Clinical Evidence of Decreased WBC

Recent case reports confirm that Latuda can cause:

  • Neutropenia during active treatment 2
  • Thrombocytopenia and potential myelosuppression 3

In the documented case of neutropenia, blood counts improved and normalized after discontinuation of lurasidone 2, which is the opposite of what your question suggests.

What Happens After Stopping Latuda

When Latuda is discontinued in patients who developed neutropenia during treatment, the expected pattern is:

  • Gradual improvement in blood cell counts
  • Return to normal range with appropriate monitoring and supportive care 2

There is no documented mechanism or clinical evidence suggesting that stopping Latuda would cause WBC elevation.

Important Clinical Pitfall

Do not confuse Latuda with clozapine. The provided guidelines extensively discuss clozapine's requirement for WBC monitoring even 4 weeks after discontinuation 4, but this does not apply to Latuda. Clozapine has a unique and severe risk of agranulocytosis requiring intensive monitoring protocols, while Latuda's hematologic risks are considerably lower and do not require the same post-discontinuation surveillance.

What to Actually Monitor

If you're seeing an elevated WBC after stopping Latuda, look for alternative explanations:

  • Concurrent infection or inflammatory process
  • Other medications the patient is taking
  • Underlying hematologic conditions
  • Stress response or other physiologic causes

The elevated WBC is not a consequence of stopping Latuda itself.

Related Questions

Does prednisone make withdrawal from Latuda (lurasidone) more difficult?
After discontinuing lurasidone (Latuda) 40 mg two weeks ago and using lorazepam (Ativan) 1 mg nightly for withdrawal symptoms, when is it safe to stop the lorazepam?
Can I switch to latuda (lurasidone) to lower my triglyceride level of 658 mg/dL?
Does lorazepam (Ativan) have a negative effect when taken with lurasidone (Latuda)?
Can a patient already taking venlafaxine (Effexor) be safely started on lurasidone (Latuda), and what dosing and monitoring precautions are required?
How should sodium‑glucose cotransporter‑2 (SGLT2) inhibitors be used in adult patients with chronic heart failure?
Is a white blood cell count of 15.5 ×10⁹/L concerning in a patient on ipratropium/albuterol (DuoNeb) and lorazepam (Ativan)?
Is oral minoxidil 2.5 mg recommended for treating androgenic alopecia in adults?
In a 30-year-old Black male (6'5", 320 lb) with high‑titer speckled antinuclear antibody, markedly elevated ribonucleoprotein antibodies, proximal muscle weakness, elevated creatine kinase, normal cardiac evaluation, and glucose‑6‑phosphate dehydrogenase deficiency, what is the most likely diagnosis, what EMG findings are expected, is the myositis inflammatory or necrotizing, what is the prognosis, and how common is this condition in men?
Which proton pump inhibitors (PPIs) are recommended for children with gastro‑esophageal reflux disease, and what are the appropriate dosing regimens?
How can I differentiate restless‑legs syndrome (RLS) pain from pain due to other causes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.